Study to Characterize Rate of Ureagenesis in Patients With Ornithine Transcarbamylase (OTC) Deficiency
Clinical trial NCT04717453 · TERMINATED
Trial details
- NCT number
- NCT04717453
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-06
- Primary completion
- 2021-12-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.